Search

A middle-aged man undergoing immunosuppressant therapy with mycophenolate-mofetil and tacrolimus developed a severe case of crusted scabies infestation after a kidney transplant. Initially misdiagnosed as xerosis cutis, his condition worsened, leading to polymicrobial sepsis and multisystem organ failure. Treatment with permethrin and ivermectin eventually resulted in complete resolution of his condition. [Extracted from the article]

A 19-year-old man developed crusted scabies (CS) while being treated with dupilumab for atopic dermatitis (AD). He also experienced a lack of efficacy with upadacitinib treatment for AD. The man had a history of severe AD and had been receiving dupilumab, which initially improved his symptoms but later worsened. After discontinuing dupilumab and starting upadacitinib, there was still no improvement, and he was referred to another hospital where a diagnosis of CS secondary to dupilumab was made. [Extracted from the article]

A 37-year-old woman with Down syndrome experienced downregulation of T helper 17 cells (Th17) while being treated with risankizumab for psoriasis. During a routine appointment, her psoriasis worsened, and she developed crusted plaques resembling the distribution of her psoriasis. Further examination revealed scabies mites, and a diagnosis of risankizumab-induced downregulation of Th17 cells was made. She received treatment for the scabies outbreak, resulting in significant improvement, although additional treatments were needed for complete resolution of the crust. [Extracted from the article]

In a case report of 5 patients, an 18-year-old man experienced treatment failure while being treated for nodular scabies with tacrolimus, prednisolone, antihistamines, and steroids. Initially, the man received sulfur treatment and saw improvement, but he later developed residual pruritic nodules and began receiving the aforementioned medications. However, his treatment was unsuccessful. As a result, he was prescribed tofacitinib, which led to complete remission. [Extracted from the article]

A 23-year-old man developed acute generalized exanthematous pustulosis while being treated with ivermectin for crusted scabies. The man had a history of cocaine and cannabis use and presented with a progressive pruritic rash. Laboratory results were unremarkable except for leukocytosis, and microscopic examination confirmed the diagnosis of crusted scabies. After starting treatment with permethrin cream and ivermectin, the man developed numerous pustules and fever. Ivermectin was discontinued, and the man eventually had a satisfactory recovery after completing the permethrin regimen. [Extracted from the article]

A 10-month-old boy in Norway developed Norwegian scabies after his mother misused clobetasol, a topical medication, to treat his general itching. The boy had crusty lesions on his palms and soles, as well as erythematous-scaling lesions all over his body. The diagnosis of Norwegian scabies was confirmed by the presence of mite eggs and feces on the skin. The boy was treated with permethrin and sodium fusidate, and his symptoms resolved within a week. [Extracted from the article]

However, it is also possible that these symptoms are due to the scabies infection, caused by a reaction of the skin to the dead scabies mites. When using Permetrin, patients should avoid hot showers, use little soap to prevent aggravation of itching, and skin should be kept oily, said Lareb. With an increase in scabies infections in the Netherlands, the Netherlands side effects centre Lareb has received increasing reports of adverse events (AEs) associated with the use of permethrin [Permetrin]. [Extracted from the article]

Norwegian Scabies in an Atopic Patient Under Dupilumab Treatment. B Author Information b An event is serious (based on the ICH definition) when the patient outcome is: * death * life-threatening * hospitalisation * disability * congenital anomaly * other medically important event A 23-year-old man developed Norwegian scabies during treatment with dupilumab for atopic dermatitis. He was diagnosed with Norwegian scabies secondary to dupilumab therapy [ I exact time to reaction onset not stated i ]. [Extracted from the article]

B Author Information b An event is serious (based on the ICH definition) when the patient outcome is: * death * life-threatening * hospitalisation * disability * congenital anomaly * other medically important event A 19-year-old man developed Norwegian scabies during treatment with prednisolone for methicillin-resistant I Staphylococcus epidermidis i infection and empirical treatment with dexamethasone [ I dosages not stated; not all routes stated i ]. He then received treatment with oral prednisolone along with amikacin injection for the methicillin-resistant I Staphylococcus epidermidis i infection for one week. The man received treatment wit permethrin and ivermectin, and the lesions healed completely within one week of treatment. [Extracted from the article]

B Author Information b An event is serious (based on the ICH definition) when the patient outcome is: * death * life-threatening * hospitalisation * disability * congenital anomaly * other medically important event A 79-year-old woman developed sub-ungual scabies during immunosuppressive treatment with prednisone. At every hospitalisation, she was diagnosed with prednisone-induced sub-ungual scabies [ I duration of treatment to reaction onset not stated i ]. Nail biopsy revealed scabies mites embedded deeply in the thick nail keratin. [Extracted from the article]

The two patients who received tetracosactide, developed side effects including diabetes mellitus (n=1) and crusted scabies (n=1). B Author Information b An event is serious (based on the ICH definition) when the patient outcome is: * death * life-threatening * hospitalisation * disability * congenital anomaly * other medically important event In a retrospective study consisting of 46 patients who underwent kidney transplantation between 1993 and 2019, four patients [ I ages and sexes not stated i ] were described who developed diabetes mellitus or crusted scabies during treatment with tetracosactide or exhibited lack of efficacy during treatment with rituximab or abatacept for recurrent focal segmental glomerulosclerosis (FSGS) [ I not all routes stated; time to reaction onsets and outcomes not stated i ]. [Extracted from the article]

B Author Information b An event is serious (based on the ICH definition) when the patient outcome is: * death * life-threatening * hospitalisation * disability * congenital anomaly * other medically important event A 57-year-old woman developed crusted scabies (Norwegian scabies) following treatment with azathioprine, mycophenolate mofetil, prednisolone and rituximab for muco-cutaneous pemphigus vulgaris (PV) [ I routes and time to reaction onsets not stated; not all dosages stated i ]. Thus, skin scraping was performed and microscopic studies showed numerous eggs and adult mites, consistent with a diagnosis of crusted scabies. Crusted scabies in a patient with pemphigus vulgaris after treatment with rituximab and corticosteroids. [Extracted from the article]

A 53-year-old woman developed Norwegian scabies following treatment with azathioprine, cyclophosphamide, mycophenolate mofetil, hydroxychloroquine, unspecified corticosteroids as immunosuppressant, and belimumab for chronic cutaneous lupus erythematosus [ I dosages and routes not stated i ]. The woman had a 20 year history of systemic lupus with chronic cutaneous lupus lesions and various other co-morbidities. Three months later, she developed pruritus associated with skin lupus lesions. [Extracted from the article]

Physical examination revealed multiple erythematous papules and pustules on almost entire body along with thick scales on the hands, elbows, nipples and buttocks. B Author comment: b I "Both patients had a weakened immune system due to long-term use of oral corticosteroid; this made them susceptible to infection, including scabies and the severe form of scabies infestation known as crusted scabies.". [Extracted from the article]

A 17-year-old boy developed bullous scabies and I Staphylococcus aureus i infection while receiving immunosuppressive treatment with tacrolimus. The rash initially started with few vesicles on his left palm, and progressed to large bullae on the bilateral palms as well as diffuse erythematous vesicles and papules. [Extracted from the article]

The article describes the case of an 11-year-old girl who developed Norwegian scabies during treatment with triamcinolone for atopic dermatitis.

The article presents a case study of a 64-year-old female patient who developed itchiness at the site of injection following treatment with bee venom for circumscribed morphea in systemic sclerosis.

The article presents a case study of a 36-year-old woman who developed DRESS syndrome during treatment with ivermectin for scabies and who was admitted to the hospital due to a pruritic generalised maculopapular rash.

The article presents a case study of an 80-year-old man who developed Norwegian scabies infection after treatment with tripterygium glycoside, an immunosuppressive agent made from Chinese medicinal herb extract.

The article presents a case study of a 46-year-old woman who during treatment with adalimumab for rheumatoid arthritis developed scabies.

The article presents a case study of a 37-year-old woman who developed crusted scabies after taking prednisone drug as treatment to her systemic lupus erythematosus infection.

The article presents a case study of a 65-year-old woman who experienced crusted scabies while medicated with adalimumab.

This article gives the case of an infant who developed crusted scabies during treatment with pimecrolimus for eczema. It presents the symptoms showed by the patient, including pruritus and scrapings. The treatments received by the patient for the disorder are stated.

An abstract of the article "Treatment for crusted scabies: Limitations and side effects of treatment with ivermectin" by K. Fujimoto and colleagues is presented.

The article presents a case study of an 8-year-old boy who developed a maculopapular itchy skin rash during treatment with gemcitabine.

The article describes the case of a 20-year-old man who developed Norwegian scabies following topical administration of beclometasone/clobetasol/mometasone.

The article describes a case of erythrodermic crusted scabies which developed in a 78-year-old man while he was being treated with prednisone and betamethasone for generalised erythematous papules and pruritus.

The article describes the case of a 39-year-old woman who developed Norwegian scabies while receiving cyclophosphamide and azathioprine for systemic scleroderma.

The article describes the case of a 47-year-old man who developed crusted scabies while under betamethasone treatment regimen for chronic alcohol abuse.

The article describes the case of an 85-year-old woman who developed Norwegian (or crusted) scabies while under immunosuppressive therapy regimen with prednisone for bullous pemphigoid. The patient complained of confluent maculous exanthema associated with pruritus after receiving prednisone. Biopsy results showed an inflammatory reaction in her upper dermis and epidermal burrows that contain parasites and faeces. Dressing with salicylic acid resolved the patient's condition.